Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 4.960
+0.010 (0.20%)
Aug 5, 2025, 11:13 AM AEST
Tetratherix Company Description
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally.
The company has used its Tetramatrix platform technology to manufacture and provide products in the areas of bone regeneration, tissue spacing, and tissue healing applications.
Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Tetratherix Limited
| Country | Australia |
| Founded | 2015 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| CEO | William Knox |
Contact Details
Address: Unit 29 Alexandria, 2015 Australia | |
| Website | tetratherix.com |
Stock Details
| Ticker Symbol | TTX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000400574 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| William Knox | Chief Executive Officer and Executive Director |
| Dr. Ali Fathi | Founder, Chief Technology Officer and Executive Director |
| Terence Abrams | Founder and Chief Operating Officer |
| Cherie Beach | Chief Financial Officer |
| Jane Miller | Joint Company Secretary |
| Sally Greenwood | Joint Company Secretary |
| Alex Washington | Financial Controller |